TY - JOUR
T1 - Small-Molecule Cyanamide Pan-TEAD·YAP1 Covalent Antagonists
AU - Bum-Erdene, Khuchtumur
AU - Yeh, I. Ju
AU - Gonzalez-Gutierrez, Giovanni
AU - Ghozayel, Mona K.
AU - Pollok, Karen
AU - Meroueh, Samy O.
N1 - The research was supported by an American Cancer Society Research Scholar Grant RSG-12-092-01-CDD (SOM), Vera Bradley Foundation fellowship (KB), Vera Bradley Foundation grant (SOM), Indiana University Simon Cancer Center Near Miss Initiative grant (SOM), and the 100 Voices of Hope (SOM).
PY - 2023/1/12
Y1 - 2023/1/12
N2 - Transcriptional enhanced associate domains (TEADs) are transcription factors that bind to cotranscriptional activators like the yes-associated protein (YAP) or its paralog transcriptional coactivator with a PDZ-binding motif (TAZ). TEAD·YAP/TAZ target genes are involved in tissue and immune homeostasis, organ size control, tumor growth, and metastasis. Here, we report isoindoline and octahydroisoindole small molecules with a cyanamide electrophile that forms a covalent bond with a conserved cysteine in the TEAD palmitate-binding cavity. Time- and concentration-dependent studies against TEAD1-4 yielded second-order rate constants kinact/KIgreater than 100 M-1s-1. Compounds inhibited YAP1 binding to TEADs with submicromolar IC50values. Cocrystal structures with TEAD2 enabled structure-activity relationship studies. In mammalian cells, compounds suppressed CTGF mRNA levels and inhibited TEAD1-4 transcriptional activity with submicromolar IC50values. Inhibition of TEAD binding to YAP1 in mammalian cells was also observed. Several compounds inhibited the cell viability of sarcoma, hepatocellular carcinoma, glioblastoma, and breast cancer cells with single-digit micromolar IC50values.
AB - Transcriptional enhanced associate domains (TEADs) are transcription factors that bind to cotranscriptional activators like the yes-associated protein (YAP) or its paralog transcriptional coactivator with a PDZ-binding motif (TAZ). TEAD·YAP/TAZ target genes are involved in tissue and immune homeostasis, organ size control, tumor growth, and metastasis. Here, we report isoindoline and octahydroisoindole small molecules with a cyanamide electrophile that forms a covalent bond with a conserved cysteine in the TEAD palmitate-binding cavity. Time- and concentration-dependent studies against TEAD1-4 yielded second-order rate constants kinact/KIgreater than 100 M-1s-1. Compounds inhibited YAP1 binding to TEADs with submicromolar IC50values. Cocrystal structures with TEAD2 enabled structure-activity relationship studies. In mammalian cells, compounds suppressed CTGF mRNA levels and inhibited TEAD1-4 transcriptional activity with submicromolar IC50values. Inhibition of TEAD binding to YAP1 in mammalian cells was also observed. Several compounds inhibited the cell viability of sarcoma, hepatocellular carcinoma, glioblastoma, and breast cancer cells with single-digit micromolar IC50values.
UR - http://www.scopus.com/inward/record.url?scp=85144776651&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85144776651&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.2c01189
DO - 10.1021/acs.jmedchem.2c01189
M3 - Article
C2 - 36562717
AN - SCOPUS:85144776651
SN - 0022-2623
VL - 66
SP - 266
EP - 284
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 1
ER -